Daniel J. Brennan

Daniel J. Brennan, listed as finance chief, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Boston Scientific Corp, Waters Corp /DE/ and Madrigal Pharmaceuticals, Inc. Over a trading history stretching from 16 December 2015 to 17 June 2026, the count stands at 35 filings.

On the market, this insider has only sold: 2 sales, €724k in total. Other entries cover 12 share grants and 19 option exercises.

On 18 June 2026 came the latest disclosure, a share grant in Madrigal Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.